Director/PDMR Shareholding

One Health

21/03/2025 14:55

RNS Number : 7312B

One Health Group PLC

21 March 2025

 

21 March 2025

One Health Group plc

("One Health" or the "Company")

PDMR/PCA Dealings

 

One Health Group plc (AQSE: OHGR), a provider of NHS-funded medical procedures, announces that further to the announcement on 19 February 2025 regarding the Capital Raising, Derek Bickerstaff, Non-Executive Chairman of One Health, has notified the Company that he has sold 450,000 ordinary shares of 0.5 pence each in the Company ("Ordinary Shares") pursuant to the Placing.

 

Shantanu Shahane, Chief Medical Officer of One Health, has also notified the Company that he has sold 25,000 Ordinary Shares pursuant to the Placing and Angela Shahane, a person closely associated to Shantanu Shahane, has notified the Company that she has sold 35,000 Ordinary Shares pursuant to the Placing.

 

Furthermore, One Health Group Trustees LLP, the trustee of the One Health Group Employee Benefit Trust and a person closely associated with Derek Bickerstaff and Adam Binns, Chief Executive Officer, has notified the Company that it has sold 684,721 Ordinary Shares pursuant to the Placing.

 

Additionally, Anthony Nicholas Parker, a Non-Executive Director of One Health, has notified the Company that he has, indirectly, subscribed for 27,777 Ordinary Shares pursuant to the Placing at the Issue Price for an aggregate amount of approximately £50,000.

 

Further details of the Ordinary Shares sold by Mr Bickerstaff, Mr Shahane, Mrs Shahane and One Health Group Trustees LLP and of the Ordinary Shares indirectly subscribed by Mr Parker pursuant to the Placing are set out below.

 

For more information, please contact:

 

One Health Group plc
Derek Bickerstaff, Chairman
Adam Binns, CEO
via Square1 Consulting
Panmure Liberum (Nominated Adviser and Broker)
Emma Earl, Will Goode, Mark Rogers, Joshua Borlant
Rupert Dearden
Tel: +44 (0) 20 3100 2000
Square1 Consulting
David Bick
Tel: +44 207 929 5599
+44 7831 381201


Further information on the Company can be found on its website at www.onehealth.co.uk.

 

This announcement should be read in its entirety. In particular, the information in the "Important Notices" section of the announcement should be read and understood.

 

About One Health Group plc

One Health engages over 70 NHS Consultants (excluding anaesthetists) who sub-specialise in the various surgeries offered by the Company, through a growing network of community-based outreach clinics and surgical operating locations. One Health continues to deliver strong growth and in the year to March 2024 provided much needed care to 13,266 new patients, through almost 34,000 consultations and over 6,000 surgical procedures. One Health deploys surgeons and anaesthetists that are mostly employed by the NHS, on a subcontracted basis. It currently works with over 100 professionals across 9 independent hospitals and 37 outreach clinics. Within these community-based outreach clinics all consultations and post operative physiotherapy is delivered where required, reducing patient inconvenience and excess travel.

One Health's activities are focused on areas where NHS patient needs are under-supplied by the local NHS service, population density is relatively high and the level of private medical insurance or the ability to self-fund is relatively low. One Health has also sought to expand geographically from its Head Office in Sheffield into neighbouring counties which meet these criteria. Currently, the Company's activities are focused in Yorkshire, Lincolnshire, Derbyshire, Nottinghamshire and Leicestershire. Revenue of over £23 million in the year to 31 March 2024 was derived from over 60 NHS commissioning bodies in addition to contracts with local NHS Hospital Trusts to transfer their internal waiting list patients to One Health for quicker treatment.

One Health's business model has focused to date on four main areas: orthopaedics, spine, general surgery and gynaecology. The split of inpatient procedures in the year to 31 March 2024 was as follows: orthopaedics 46% spine 22% general surgery 22% gynaecology 10%.

Spine and orthopaedics are particularly attractive areas for One Health as the Directors believe that they benefit from powerful growth drivers in terms of an ageing demographic, physical inactivity and an increasing proportion of the population being categorised as obese. Within orthopaedics, the most common surgeries performed by One Health are knee and hip replacements.

*(https://www.onehealth.co.uk/investors)

The Directors of One Health Group plc accept responsibility for the contents of this announcement

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name:
Shantanu Shahane
2.
Reason for the notification
a)
Position/status:
Chief Medical Officer
b
Initial notification/Amendment:
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name:
One Health Group plc
b)
LEI:
984500DC689F5BAD8732
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument:

 Identification code:
Ordinary shares of £0.005 each

 ISIN Code: GB00BNNT0595
b)
Nature of the transaction:
Sale of shares
c)
Price(s) and Volume (s):
Sale price(s). £1.80
Volume(s): 25,000
d)
Aggregated Information:

 Aggregated volume:

 Price:
N/A
e)
Date of the transaction:
20 March 2025
f)
Place of the transaction
London Stock Exchange (AIM)

 

1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name:
Angela Shahane
2.
Reason for the notification
a)
Position/status:
Person closely associated with Shantanu Shahane, Chief Medical Officer
b
Initial notification/Amendment:
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name:
One Health Group plc
b)
LEI:
984500DC689F5BAD8732
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument:

 Identification code:
Ordinary shares of £0.005 each

 ISIN Code: GB00BNNT0595
b)
Nature of the transaction:
Sale of shares
c)
Price(s) and Volume (s):
Purchase price(s). £1.80
Volume(s):35,000
d)
Aggregated Information:

 Aggregated volume:

 Price:
N/A
e)
Date of the transaction:
20 March 2025
f)
Place of the transaction
London Stock Exchange (AIM)

 

1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name:
Derek Bickerstaff
2.
Reason for the notification
a)
Position/status:
Non-Executive Chairman
b
Initial notification/Amendment:
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name:
One Health Group plc
b)
LEI:
984500DC689F5BAD8732
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument:

 Identification code:
Ordinary shares of £0.005 each

 ISIN Code: GB00BNNT0595
b)
Nature of the transaction:
Sale of shares
c)
Price(s) and Volume (s):
Sale price(s). £1.80
Volume(s): 450,000
d)
Aggregated Information:

 Aggregated volume:

 Price:
N/A
e)
Date of the transaction:
20 March 2025
f)
Place of the transaction
London Stock Exchange (AIM)

 

1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name:
One Health Group Trustees LLP
2.
Reason for the notification
a)
Position/status:
Person closely associated with Derek Bickerstaff, Non-Executive Chairman and Adam Binns, Chief Executive
b
Initial notification/Amendment:
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name:
One Health Group plc
b)
LEI:
984500DC689F5BAD8732
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument:

 Identification code:
Ordinary shares of £0.005 each

 ISIN Code: GB00BNNT0595
b)
Nature of the transaction:
Sale of shares
c)
Price(s) and Volume (s):
Purchase price(s). £1.80
Volume(s): 684,721
d)
Aggregated Information:

 Aggregated volume:

 Price:
N/A
e)
Date of the transaction:
20 March 2025
f)
Place of the transaction
London Stock Exchange (AIM)

 

1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name:
Anthony Nicholas Parker
2.
Reason for the notification
a)
Position/status:
Non-Executive Director
b
Initial notification/Amendment:
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name:
One Health Group plc
b)
LEI:
984500DC689F5BAD8732
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument:

 Identification code:
Ordinary shares of £0.005 each

 ISIN Code: GB00BNNT0595
b)
Nature of the transaction:
Purchase of shares
c)
Price(s) and Volume (s):
Purchase price(s). £1.80
Volume(s): 27,777
d)
Aggregated Information:

 Aggregated volume:

 Price:
N/A
e)
Date of the transaction:
20 March 2025
f)
Place of the transaction
London Stock Exchange (AIM)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHBSGDXDUDDGUB